Literature DB >> 22845398

Tumor microenvironment regulates epithelial-mesenchymal transitions in metastasis.

Dingcheng Gao, Vivek Mittal.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22845398      PMCID： PMC4656980          DOI： 10.1586/era.12.69

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN： 1473-7140            Impact factor:   4.512


× No keyword cloud information.
  24 in total

Review 1.  Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition?

Authors:  Erik W Thompson; Donald F Newgreen; David Tarin
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

2.  Phenotypic plasticity and epithelial-mesenchymal transitions in cancer and normal stem cells?

Authors:  Christina Scheel; Robert A Weinberg
Journal:  Int J Cancer       Date:  2011-08-29       Impact factor: 7.396

Review 3.  Prostate tumor cell plasticity: a consequence of the microenvironment.

Authors:  Clayton Yates
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

4.  Tumour evolution inferred by single-cell sequencing.

Authors:  Nicholas Navin; Jude Kendall; Jennifer Troge; Peter Andrews; Linda Rodgers; Jeanne McIndoo; Kerry Cook; Asya Stepansky; Dan Levy; Diane Esposito; Lakshmi Muthuswamy; Alex Krasnitz; W Richard McCombie; James Hicks; Michael Wigler
Journal:  Nature       Date:  2011-03-13       Impact factor: 49.962

Review 5.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

6.  Bone morphogenetic protein 7 induces mesenchymal-to-epithelial transition in melanoma cells, leading to inhibition of metastasis.

Authors:  Yi-Rang Na; Seung-Hyeok Seok; Dong-Jae Kim; Ju-Hee Han; Tae-Hyoun Kim; Hyun Jung; Byoung-Hee Lee; Jae-Hak Park
Journal:  Cancer Sci       Date:  2009-07-30       Impact factor: 6.716

Review 7.  The basics of epithelial-mesenchymal transition.

Authors:  Raghu Kalluri; Robert A Weinberg
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

8.  Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics.

Authors:  Bryan T Hennessy; Ana-Maria Gonzalez-Angulo; Katherine Stemke-Hale; Michael Z Gilcrease; Savitri Krishnamurthy; Ju-Seog Lee; Jane Fridlyand; Aysegul Sahin; Roshan Agarwal; Corwin Joy; Wenbin Liu; David Stivers; Keith Baggerly; Mark Carey; Ana Lluch; Carlos Monteagudo; Xiaping He; Victor Weigman; Cheng Fan; Juan Palazzo; Gabriel N Hortobagyi; Laura K Nolden; Nicholas J Wang; Vicente Valero; Joe W Gray; Charles M Perou; Gordon B Mills
Journal:  Cancer Res       Date:  2009-05-12       Impact factor: 12.701

9.  Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.

Authors:  Manav Korpal; Brian J Ell; Francesca M Buffa; Toni Ibrahim; Mario A Blanco; Toni Celià-Terrassa; Laura Mercatali; Zia Khan; Hani Goodarzi; Yuling Hua; Yong Wei; Guohong Hu; Benjamin A Garcia; Jiannis Ragoussis; Dino Amadori; Adrian L Harris; Yibin Kang
Journal:  Nat Med       Date:  2011-08-07       Impact factor: 53.440

10.  Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility.

Authors:  Silvia Giampieri; Cerys Manning; Steven Hooper; Louise Jones; Caroline S Hill; Erik Sahai
Journal:  Nat Cell Biol       Date:  2009-10-18       Impact factor: 28.824
View more
  7 in total

Review 1.  Crosstalk between cancer cells and blood endothelial and lymphatic endothelial cells in tumour and organ microenvironment.

Authors:  Esak Lee; Niranjan B Pandey; Aleksander S Popel
Journal:  Expert Rev Mol Med       Date:  2015-01-30       Impact factor: 5.600

Review 2.  A weighty problem: metabolic perturbations and the obesity-cancer link.

Authors:  Ciara H O'Flanagan; Laura W Bowers; Stephen D Hursting
Journal:  Horm Mol Biol Clin Investig       Date:  2015-08

3.  Preclinical Efficacy and Safety Assessment of Artemisinin-Chemotherapeutic Agent Conjugates for Ovarian Cancer.

Authors:  Xiaoguang Li; Yu Zhou; Yanling Liu; Xu Zhang; Tao Chen; Kerong Chen; Qian Ba; Jingquan Li; Hong Liu; Hui Wang
Journal:  EBioMedicine       Date:  2016-11-23       Impact factor: 8.143

Review 4.  Paradigm shift in the pathogenesis and treatment of oral cancer and other cancers focused on the oralome and antimicrobial-based therapeutics.

Authors:  Allan Radaic; Sean Ganther; Pachiyappan Kamarajan; Jennifer Grandis; Sue S Yom; Yvonne L Kapila
Journal:  Periodontol 2000       Date:  2021-10       Impact factor: 7.589

Review 5.  Cancer drug resistance induced by EMT: novel therapeutic strategies.

Authors:  Javier De Las Rivas; Anamaria Brozovic; Sivan Izraely; Alba Casas-Pais; Isaac P Witz; Angélica Figueroa
Journal:  Arch Toxicol       Date:  2021-05-18       Impact factor: 5.153

Review 6.  Epithelial to Mesenchymal Transition History: From Embryonic Development to Cancers.

Authors:  Camille Lachat; Paul Peixoto; Eric Hervouet
Journal:  Biomolecules       Date:  2021-05-22

7.  Jiedu Sangen Decoction Inhibits Migration and Invasion of Colon Cancer SW480 Cells via Suppressing Epithelial Mesenchymal Transition.

Authors:  Kai Zhang; Tao Peng; Qingying Yan; Leitao Sun; Haojun Miao; Li Yuan; Yuxin Hong; Mengmeng Zhou; Kaibo Guo; Leyin Zhang; Jing Fang; Minhe Shen; Shanming Ruan
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-25       Impact factor: 2.629
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.